We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 2,403 results
  1. Prognosis of isolated locoregional recurrence after early breast cancer with immediate breast reconstruction surgery: a retrospective multi‑institutional study

    Background

    The prognosis in patients with breast cancer with isolated locoregional recurrence (ILRR) without simultaneous distant metastases after...

    Hirohito Seki, Akiko Ogiya, ... Tadahiko Shien in Breast Cancer
    Article 19 June 2024
  2. Exploration of treatment strategies and susceptibility gene of postoperative nausea and vomiting in breast cancer patients: a randomised controlled trial

    Background

    A history of severe nausea and vomiting during pregnancy (SNVP) is a risk factor for postoperative nausea and vomiting (PONV). This study...

    Baona Wang, Huaqing Chu, ... Hui Zheng in Breast Cancer
    Article 19 June 2024
  3. Impact of immediate breast reconstruction on perioperative therapy: insights from a Japanese Nationwide Registry

    Background

    Immediate breast reconstruction (IBR) is a common oncoplastic procedure used in breast cancer surgery. This study aims to investigate...

    Shinsuke Sasada, Hiraku Kumamaru, ... Shigehira Saji in Breast Cancer
    Article Open access 19 June 2024
  4. Trastuzumab deruxtecan versus treatment of physician’s choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study

    Background

    In the global phase 3 DESTINY-Breast04 study (NCT03734029), the anti-human epidermal growth factor 2 (HER2) antibody–drug conjugate...

    Toshinari Yamashita, Joo Hyuk Sohn, ... Junji Tsurutani in Breast Cancer
    Article Open access 17 June 2024
  5. Cost-effectiveness of adjuvant endocrine treatment with tamoxifen for male breast cancer

    Background

    Tamoxifen (TAM) is recommended as the first-line strategy for men with estrogen receptor (ER)-positive early breast cancer who are...

    Ya** Huang, Chengjie Ke, ... Hong Sun in Breast Cancer
    Article 15 June 2024
  6. Neoadjuvant talazoparib in patients with germline BRCA1/2 mutation-positive, early-stage triple-negative breast cancer: exploration of tumor BRCA mutational status

    Background

    Talazoparib monotherapy in patients with germline BRCA -mutated, early-stage triple-negative breast cancer (TNBC) showed activity in the...

    Melinda L. Telli, Jennifer K. Litton, ... Joanne L. Blum in Breast Cancer
    Article Open access 13 June 2024
  7. Delayed breast reconstruction with autologous free flap after radiation therapy: vascular complications and aesthetic outcomes

    Background

    The safety and outcome of breast reconstruction after radiotherapy are controversial, and the aesthetic aspects have not been studied...

    Kimie Miyazawa, Toshihiko Satake, ... Takashi Ishikawa in Breast Cancer
    Article 12 June 2024
  8. Validation of late recurrence prediction by gene expression profiles and clinicopathological factors in estrogen receptor-positive breast cancer

    Background

    The mechanism of late recurrence (LR) of estrogen receptor (ER)-positive breast cancer remains unclear, as previous studies have separately...

    Sae Kitano, Ryo Tsunashima, ... Yasuto Naoi in Breast Cancer
    Article 11 June 2024
  9. Breast cancer epigenetics: current and evolving treatment

    Background

    Breast cancer (BC) presents persistent challenges due to subtype-specific limited efficacy and potential resistance to standard therapy,...

    Sujata Purja, Dung Thuy Nguyen, Eunyoung Kim in Breast Cancer
    Article 11 June 2024
  10. Exosomal lncRNA SNHG12 promotes angiogenesis and breast cancer progression

    Objective

    Breast cancer is one of the most prevalent malignancies in women. Exosomes are important mediators of intercellular communication; however,...

    Yan Chen, Yuxin Zhou, ... Weizhu Wu in Breast Cancer
    Article Open access 04 June 2024
  11. Comparison of water- vs. land-based exercise for improving functional capacity and quality of life in patients living with and beyond breast cancer (the AQUA-FiT study): a randomized controlled trial

    Background

    Patients living with and beyond breast cancer frequently exhibit several side effects that can impact quality of life and physical...

    E. Mur-Gimeno, M. Coll, ... R. Sebio-García in Breast Cancer
    Article 30 May 2024
  12. Contrast-enhanced mammography in the management of breast architectural distortions and avoidance of unnecessary biopsies

    Background

    To assess contrast-enhanced mammography (CEM) in the management of BI-RADS3 breast architectural distortions (AD) in digital breast...

    Chiara Bellini, Francesca Pugliese, ... Jacopo Nori in Breast Cancer
    Article 29 May 2024
  13. A novel nomogram and survival analysis for different lymph node status in breast cancer based on the SEER database

    Introduction

    The axillary lymph node status (ALNS) and internal mammary lymph nodes (IMLN) expression associated with breast cancer are closely linked...

    Lizhi Teng, Juntong Du, ... Weiyang Tao in Breast Cancer
    Article Open access 27 May 2024
  14. Assessing the effectiveness of high frequency repetitive transcranial magnetic stimulation for post-mastectomy pain in breast cancer patients: A randomized controlled trial

    Background

    Post-mastectomy pain Syndrome (PMPS), characterized by chronic neuropathic pain stemming from intercostobrachial nerve lesions, presents a...

    Monika Kataria, Nishkarsh Gupta, ... Renu Bhatia in Breast Cancer
    Article 26 May 2024
  15. A randomized trial of the impact of symptom monitoring using an electronic patient-reported outcome app on health-related quality of life in postmenopausal breast cancer patients receiving adjuvant endocrine therapy

    Background

    Electronic patient-reported outcomes (ePRO) monitoring is a useful communication tool for cancer patients and healthcare providers. In this...

    Hiromi Okuyama, Fuka Takada, ... Seigo Nakamura in Breast Cancer
    Article 26 May 2024
  16. Antitumor effects of co-treatment of resveratrol with antitumor drugs in ER- and HER2-positive breast cancer cells are due to induction of apoptosis and modulation of estrogen receptor expression

    Background

    Resveratrol, a natural compound, may be an alternative to improving conventional breast cancer therapy. Thus, we assessed the capability of...

    Beatriz Tinoco Franceschi, Patrícia Heloise Alves Bezerra, Maria Regina Torqueti in Breast Cancer
    Article 23 May 2024
  17. Mesenchymal-like immune-altered is the fourth robust triple-negative breast cancer molecular subtype

    Background

    Robust molecular subty** of triple-negative breast cancer (TNBC) is a prerequisite for the success of precision medicine. Today, there is...

    Pascal Jézéquel, Hamza Lasla, ... Mario Campone in Breast Cancer
    Article 22 May 2024
  18. Resilience’s impact on quality of life and post-traumatic growth in breast cancer patients during treatment

    Background

    This article aims to examine how psychological resilience influences the interplay between quality of life and post-traumatic growth among...

    Songül Duran, Umut Varol, ... Ahmet Hakan Soytürk in Breast Cancer
    Article Open access 17 May 2024
Did you find what you were looking for? Share feedback.